Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) Operating Expenses (2016 - 2025)

Sanara MedTech's Operating Expenses history spans 15 years, with the latest figure at $24.6 million for Q4 2025.

  • For Q4 2025, Operating Expenses rose 12.96% year-over-year to $24.6 million; the TTM value through Dec 2025 reached $93.7 million, up 17.31%, while the annual FY2025 figure was $88.3 million, 14.26% up from the prior year.
  • Operating Expenses reached $24.6 million in Q4 2025 per SMTI's latest filing, up from $21.5 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $24.6 million in Q4 2025 to a low of $5.6 million in Q1 2021.
  • Average Operating Expenses over 5 years is $15.8 million, with a median of $15.8 million recorded in 2022.
  • Peak YoY movement for Operating Expenses: surged 96.19% in 2022, then grew 0.36% in 2023.
  • A 5-year view of Operating Expenses shows it stood at $9.7 million in 2021, then soared by 66.31% to $16.1 million in 2022, then grew by 0.36% to $16.1 million in 2023, then skyrocketed by 35.15% to $21.8 million in 2024, then rose by 12.96% to $24.6 million in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Operating Expenses are $24.6 million (Q4 2025), $21.5 million (Q3 2025), and $23.9 million (Q2 2025).